ArticleEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2025
Clinical and imaging characteristics of giant cell tumor in patients aged 18 and below.
Article in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveTo investigate the clinical and imaging characteristics of giant cell tumors (GCT) in patients aged 18 and under.
methodsThis retrospective study analyzed clinical and imaging data from 12 patients aged 18 and below with histopathologically confirmed GCT, treated at xxx hospital from January 2015 to December 2023. Collected data included patient demographics, clinical presentation, anatomical tumor location, and imaging features from X-rays, CT scans, and MRI. Histopathological examination and immunohistochemistry were performed to confirm diagnoses and assess tumor characteristics.
resultsThe study included 12 patients (6 males, 6 females) with a mean age of 15.5 years. The most common presenting symptoms were localized pain and swelling. The proximal tibia was the most frequently affected site. Imaging studies consistently showed osteolytic bone destruction with features such as eccentric growth patterns, sclerotic margins, periosteal reaction, and cystic changes. Pathological fractures were noted in five patients. MRI provided detailed insights into the internal architecture of the tumors, including fluid-fluid levels. Histopathology confirmed the presence of multinucleated giant cells within a stromal background. Immunohistochemical analysis showed that RANKL, VEGF, MMP-9, and Ki-67 were variably expressed across cases, with statistically higher expression levels of RANKL and MMP-9 observed in patients with pathological fractures and open epiphyseal plates, respectively.
conclusionGCT in patients aged 18 and under presents distinct clinical and imaging features that are crucial for accurate diagnosis and effective treatment planning. Recognizing these characteristics is essential for managing this rare but significant bone tumor in the pediatric and adolescent population.
Indexed as
Identifiers
40442519What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.